Kinetics, Thermodynamics, and Structural Effects of Quinoline-2-Carboxylates, Zinc-Binding Inhibitors of New Delhi Metallo-β-lactamase-1 Re-sensitizing Multidrug-Resistant Bacteria for Carbapenems

被引:10
|
作者
Jia, Yuwen [1 ]
Schroeder, Barbara [1 ]
Pfeifer, Yvonne [2 ]
Froehlich, Christopher [3 ]
Deng, Lihua [1 ]
Arkona, Christoph [1 ]
Kuropka, Benno [4 ]
Sticht, Jana [4 ]
Ataka, Kenichi [5 ]
Bergemann, Silke [1 ]
Wolber, Gerhard [1 ]
Nitsche, Christoph [6 ]
Mielke, Martin [7 ]
Leiros, Hanna-Kirsti S. [3 ]
Werner, Guido [2 ]
Rademann, Joerg [1 ]
机构
[1] Free Univ Berlin, Inst Pharm, D-14195 Berlin, Germany
[2] Robert Koch Inst, Dept Infect Dis, FG13 Nosocomial Pathogens & Antibiot Resistances, D-38855 Wernigerode, Germany
[3] UiT Arctic Univ Norway, Fac Sci & Technol, Dept Chem, N-9037 Tromso, Norway
[4] Free Univ Berlin, Inst Chem & Biochem, Core Facil BioSupraMol, D-14195 Berlin, Germany
[5] Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany
[6] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia
[7] Robert Koch Inst, Dept Infect Dis, D-13353 Berlin, Germany
关键词
METALLO-BETA-LACTAMASE; PROTEIN SECONDARY STRUCTURE; DIPICOLINIC ACID; ASPERGILLOMARASMINE; NDM-1; DERIVATIVES; PSEUDOMONAS; SCAFFOLD; VIM-2; DRUGS;
D O I
10.1021/acs.jmedchem.3c00171
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Carbapenemresistance mediated by metallo-& beta;-lactamases (MBL)such as New Delhi metallo-& beta;-lactamase-1 (NDM-1) has become amajor factor threatening the efficacy of essential & beta;-lactamantibiotics. Starting from hit fragment dipicolinic acid (DPA), 8-hydroxy-and 8-sulfonamido-quinoline-2-carboxylic acids were developed as inhibitorsof NDM-1 with highly improved inhibitory activity and binding affinity.The most active compounds formed reversibly inactive ternary protein-inhibitorcomplexes with two zinc ions as proven by native protein mass spectrometryand bio-layer interferometry. Modification of the NDM-1 structurewith remarkable entropic gain was shown by isothermal titration calorimetryand NMR spectroscopy of isotopically labeled protein. The best compoundswere potent inhibitors of NDM-1 and other representative MBL withno or little inhibition of human zinc-binding enzymes. These inhibitorssignificantly reduced the minimum inhibitory concentrations (MIC)of meropenem for multidrug-resistant bacteria recombinantly expressing bla (NDM-1) as well as for several multidrug-resistantclinical strains at concentrations non-toxic to human cells.
引用
收藏
页码:11761 / 11791
页数:31
相关论文
共 4 条
  • [1] NMR Characterization of the Influence of Zinc(II) Ions on the Structural and Dynamic Behavior of the New Delhi Metallo-β-Lactamase-1 and on the Binding with Flavonols as Inhibitors
    Riviere, Gwladys
    Oueslati, Saoussen
    Gayral, Maud
    Crechet, Jean-Bernard
    Nhiri, Naima
    Jacquet, Eric
    Cintrat, Jean-Christophe
    Giraud, Francois
    van Heijenoort, Carine
    Lescop, Ewen
    Pethe, Stephanie
    Iorga, Bogdan I.
    Naas, Thierry
    Guittet, Eric
    Morellet, Nelly
    ACS OMEGA, 2020, 5 (18): : 10466 - 10480
  • [2] Environmental Spread of New Delhi Metallo-β-Lactamase-1-Producing Multidrug-Resistant Bacteria in Dhaka, Bangladesh
    Islam, Mohammad Aminul
    Islam, Moydul
    Hasan, Rashedul
    Hossain, M. Iqbal
    Nabi, Ashikun
    Rahman, Mahdia
    Goessens, Wil H. F.
    Endtz, Hubert P.
    Boehm, Alexandria B.
    Faruque, Shah M.
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2017, 83 (15)
  • [3] Occurrence and characterization of multidrug-resistant New Delhi metallo-β-lactamase-1-producing bacteria isolated between 2003 and 2010 in Bangladesh
    Islam, Mohammad Aminul
    Huq, Mohsina
    Nabi, Ashikun
    Talukdar, Prabhat Kumar
    Ahmed, Dilruba
    Talukder, Kaisar Ali
    Cravioto, Alejandro
    Endtz, Hubert P.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 62 : 62 - 68
  • [4] Monitoring Ceftazidime-Avibactam and Aztreonam Concentrations in the Treatment of a Bloodstream Infection Caused by a Multidrug-Resistant Enterobacter sp. Carrying Both Klebsiella pneumoniae Carbapenemase-4 and New Delhi Metallo-β-Lactamase-1
    Yasmin, Mohamad
    Fouts, Derrick E.
    Jacobs, Michael R.
    Haydar, Hanan
    Marshall, Steven H.
    White, Richard
    D'Souza, Roshan
    Lodise, Thomas P.
    Rhoads, Daniel D.
    Hujer, Andrea M.
    Rojas, Laura J.
    Hoyen, Claudia
    Perez, Federico
    Edwards, Amy
    Bonomo, Robert A.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (04) : 1095 - 1098